Egaten Tablet
Product Images NDC 0078-0937

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Egaten (NDC 0078-0937). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure Of Triclabendazole Is A White Or Almost White, Crystalline Powder. (Egaten 01)

Chemical structure of triclabendazole, showing its molecular arrangement including chlorine atoms and other functional groups, as depicted in the image.*

FDA Label Image

Principal Display Panelegaten™(triclabendazole)tablets250 mgndc 0078-0937-91rx Only4 Scored Tabletsnovartis (Egaten 02)

Packaging label for Egaten (triclabendazole) tablets, 250 mg per tablet, oral dosage form. The carton contains 4 scored tablets and is labeled for prescription use. The product is manufactured by SwissCo Services AG and distributed by Novartis Pharmaceuticals Corporation. The NDC number 0078-0937-91 is visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.